Abstract
Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.
Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.
Current Pharmacogenomics and Personalized Medicine
Title:Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Volume: 15 Issue: 1
Author(s): Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida and Michele Ciccarelli*
Affiliation:
- Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi (Salerno),Italy
Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.
Abstract: Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.
Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.Export Options
About this article
Cite this article as:
Finelli Rosa, Pascale V. Antonietta , Marotta Paola, Guida Anna and Ciccarelli Michele*, Tackling Cardiovascular Risk: New Evidence from Personalized Medicine, Current Pharmacogenomics and Personalized Medicine 2017; 15 (1) . https://dx.doi.org/10.2174/1875692115666170508152128
DOI https://dx.doi.org/10.2174/1875692115666170508152128 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Muscle Development and Regeneration in Normal and Pathological Conditions: Learning from Drosophila
Current Pharmaceutical Design The Role of Corticosteroids in Allergic Rhinitis Treatment
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling
Current Molecular Pharmacology The Role of Statins in Oxidative Stress and Cardiovascular Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Skeletal Effects of Systemic and Topical Corticosteroids
Current Drug Safety A Novel Combined Pharmacophore Mapping and Quantitative Structure Selectivity Relationship Analysis for the Development of Potent and Selective Human Aldose Reductase Inhibitors
Current Computer-Aided Drug Design Imaging Studies in Hypercalcemia
Current Medicinal Chemistry Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Current Pharmaceutical Design Prevention of Sexually Transmitted Human Immunodeficiency Virus (HIV) Infection in Adolescents
Current HIV Research A Valuable Animal Model of Spinal Cord Injury to Study Motor Dysfunctions, Comorbid Conditions, and Aging Associated Diseases
Current Pharmaceutical Design Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Current Pharmaceutical Design Scaffolds for Blocking Protein-Protein Interactions
Current Topics in Medicinal Chemistry The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
Current Cancer Drug Targets Role of Cardiolipin in Mitochondrial Diseases and Apoptosis
Current Medicinal Chemistry DNAJ Proteins and Protein Aggregation Diseases
Current Topics in Medicinal Chemistry Imaging and Laboratory Biomarkers in Cardiovascular Disease
Current Pharmaceutical Design Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Cannabinoids: Occurrence and Medicinal Chemistry
Current Medicinal Chemistry Uptake and Metabolism of the Short-Chain Fatty Acid Butyrate, a Critical Review of the Literature
Current Drug Metabolism